Skip to main content

Table 1 Immunohistochemical staining for HER 2 according to clinical characteristics of patients, stage and histological type of tumor

From: The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients

Patient characteristics Number of patients HER 2 +(%)
Total Patients 73 21 (28.8)
Sex   
Male 69 19 (27.5)
Female 4 2 (50)
Stage   
Stage IIIB 30 9 (30)
Stage IV 43 12 (27.9)
Histopathology   
Adenocarcinoma 27 11 (40.7)
Squamous cell (Epidermoid) 34 5 (14.7)
Not otherwise specified (NOS) 12 5 (41.6)